From: N-glycan alterations are associated with drug resistance in human hepatocellular carcinoma
Enzyme | Cell line | mRNA expression (ratio against HLE) | S.D. | p Value (vs HLE) |
---|---|---|---|---|
α1,6-FucT | HLE | 1.000 | 0.212 | - |
 | HLE-EPI | 1.100 | 0.062 | 0.402 |
 | HLE-MIT | 1.832 | 0.454 | 0.016 |
GnT-IVa | HLE | 1.000 | 0.136 | - |
 | HLE-EPI | 0.037 | 0.005 | 7.897 × 10-6 |
 | HLE-MIT | 0.003 | 0.001 | 6.421 × 10-6 |
GnT-IVb | HLE | 1.000 | 0.170 | - |
 | HLE-EPI | 1.304 | 0.124 | 0.028 |
 | HLE-MIT | 0.561 | 0.085 | 0.004 |
GnT-V | HLE | 1.000 | 0.428 | - |
 | HLE-EPI | 0.302 | 0.105 | 0.019 |
 | HLE-MIT | 0.122 | 0.044 | 0.006 |